- ByInvesting.com-
Investing.com -- Novo Nordisk plans to sell its weight-loss drugs through the telehealth platform of Hims & Hers Health,...
Last | High | Low | |||||
|---|---|---|---|---|---|---|---|
| 325.5 | 327.0 | 320.4 | +7.9 | +2.49% | 914.55K | ||
| 900.8 | 902.6 | 890.0 | +7.0 | +0.78% | 219.59K | ||
| 1,646.0 | 1,673.5 | 1,621.5 | +53.5 | +3.36% | 285.88K | ||
| 247.0 | 255.6 | 245.9 | -7.6 | -2.99% | 5.39M | ||
| 16,340 | 16,535 | 15,945 | -230 | -1.39% | 16.91K | ||
| 351.9 | 357.6 | 348.9 | -3.1 | -0.87% | 741.67K | ||
| 15,990 | 16,200 | 15,600 | -160 | -0.99% | 8.48K | ||
| 833.5 | 846.5 | 827.0 | +26.5 | +3.28% | 157.23K | ||
| 1,789.5 | 1,798.0 | 1,753.0 | +64.5 | +3.74% | 110.76K | ||
| 533.0 | 539.0 | 531.0 | +15.5 | +3.00% | 98.86K | ||
| 157.9 | 161.0 | 156.7 | +3.3 | +2.13% | 2.44M | ||
| 192.5 | 195.3 | 189.1 | +4.1 | +2.18% | 371.64K | ||
| 153.9 | 155.9 | 153.8 | -0.7 | -0.45% | 764.28K | ||
| 453.6 | 461.0 | 452.1 | +4.8 | +1.07% | 362.03K | ||
| 911.0 | 919.5 | 901.5 | +23.0 | +2.59% | 99.5K | ||
| 479.5 | 496.5 | 479.5 | -7.0 | -1.44% | 398.27K | ||
| 184 | 190 | 183 | +7 | +3.96% | 547.04K | ||
| 259.70 | 271.90 | 257.20 | +3.90 | +1.52% | 562.23K | ||
| 219.00 | 220.00 | 215.40 | +5.40 | +2.53% | 376.91K | ||
| 148.90 | 148.90 | 142.70 | +6.95 | +4.90% | 990.75K |
Investing.com -- Novo Nordisk plans to sell its weight-loss drugs through the telehealth platform of Hims & Hers Health,...
Investing.com - The U.S. will accept no deal with Iran except "unconditional surrender," President Donald Trump said on Friday, as...
Investing.com - A.P. Moller-Maersk and Hapag-Lloyd have halted shipping routes through the Middle East, in the latest indication...
Novo Nordisk A/S experienced a dramatic stock decline following the company’s surprise pre-release of its 2026 forecast late...
It’s no secret that the Trump administration is skeptical, to put it mildly, of alternative energy. If that was a signal for...
Novo Nordisk A/S (NYSE:NVO) announced that CEO Lars Fruergaard Jørgensen is stepping down amid mounting challenges, with the...
No Earning Reports have been scheduled